Evidence map›Paper›PMID 33542788›Full record

ReviewNutrition research and practice2021

Validation of soy isoflavone intake and its health effects: a review of the development of exposure biomarkers.

Hwan-Hee Jang, Young-Min Lee, Jeong-Sook Choe, Oran Kwon

Open access · diamondAbstract readReview
In one paragraph

Review in Nutrition research and practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Hwan-Hee JangNational Institute of Agricultural Sciences, Rural Development Administration, Wanju 55365, Korea.ORCID https://orcid.org/0000-0003-2333-9333
Young-Min LeeDivision of Applied Food System, Major of Food and Nutrition, Seoul Women's University, Seoul 01797, Korea.ORCID https://orcid.org/0000-0002-3335-2067
Jeong-Sook ChoeNational Institute of Agricultural Sciences, Rural Development Administration, Wanju 55365, Korea.ORCID https://orcid.org/0000-0002-2380-0591
Oran KwonDepartment of Nutritional Science and Food Management, Ewha Womans University, Seoul 03765, Korea.ORCID https://orcid.org/0000-0002-2031-7238
Ewha Womans University · KRRural Development Administration · KRSeoul Women's University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesIt is difficult to consistently demonstrate the health effects of soy isoflavones owing to the multitude of factors contributing to their bioavailability. To accurately verify these health effects, dietary isoflavone intake should be measured using a biologically active dose rather than an intake dose. This concept has been expanded to the development of new exposure biomarkers in nutrition research. This review aims to provide an overview of the development of exposure biomarkers and suggest a novel research strategy for identifying the health effects of soy isoflavone intake. MATERIALS/

methodsWe cover recent studies on the health effects of soy isoflavones focusing on isoflavone metabolites as exposure biomarkers.

resultsCompared to non-fermented soy foods, fermented soy foods cause an increased concentration of isoflavones in the biofluid immediately following ingestion. The correlation between exposure biomarkers in blood and urine and the food frequency questionnaire was slightly lower than that of corresponding 24-h dietary recalls. Urinary and blood isoflavone levels did not show a consistent association with chronic disease and cancer risk.

conclusionIt is crucial to understand the variable bioavailabilities of soy isoflavones, which may affect evaluations of soy isoflavone intake in health and disease. Further studies on the development of valid exposure biomarkers are needed to thoroughly investigate the health effects of isoflavone.

Indexed as

biological availabilityclinical studydietary exposurefermentationmetabolomicsSoybeans

Identifiers

PMID33542788
PMCPMC7838478
OpenAlexW3047462117

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.